Filing Details
- Accession Number:
- 0001209191-23-011655
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-22 16:25:25
- Reporting Period:
- 2023-02-17
- Accepted Time:
- 2023-02-22 16:25:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-17 | 3,750 | $292.85 | 44,248 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-02-21 | 36 | $291.01 | 44,212 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-21 | 1,223 | $292.76 | 42,989 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-21 | 1,843 | $294.03 | 41,146 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-21 | 900 | $294.73 | 40,246 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $292.76 (range $292.25 to $293.12).
- Open market sales reported on this line occurred at a weighted average price of $294.03 (range $293.45 to $294.42).
- Open market sales reported on this line occurred at a weighted average price of $294.73 (range $294.47 to $295.37).
Billionaire Hedge Funds
